2022
DOI: 10.5114/pjr.2022.116548
|View full text |Cite
|
Sign up to set email alerts
|

Feature-tracking cardiac magnetic resonance method: a valuable marker of replacement fibrosis in hypertrophic cardiomyopathy

Abstract: Purpose: Left ventricular (LV) replacement fibrosis is a marker of adverse cardiac events in hypertrophic cardiomyopathy (HCM). We aimed to assess the efficacy of the feature-tracking cardiac magnetic resonance (FT-CMR) in the detection of LV replacement fibrosis. Material and methods:Fifty-one patients with HCM (51% female, mean age = 21 ± 5.2 years) and significant myocardial hypertrophy, who underwent CMR between February 2018 and December 2019 were enrolled. Functional and 3D FT-CMR parameters were measure… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…A previous study proved that CMR-FT parameters were impaired even in the carriers of HCM without the overt disease (19). Therefore, we suppose that CMR-derived strain values, influenced by myocardial fibers disarray, may reveal (20)(21)(22). According to previous investigations, we assumed that an increased LVOT gradient, indicative of LVOT obstruction, might influence strain parameters (22).…”
Section: Discussionmentioning
confidence: 99%
“…A previous study proved that CMR-FT parameters were impaired even in the carriers of HCM without the overt disease (19). Therefore, we suppose that CMR-derived strain values, influenced by myocardial fibers disarray, may reveal (20)(21)(22). According to previous investigations, we assumed that an increased LVOT gradient, indicative of LVOT obstruction, might influence strain parameters (22).…”
Section: Discussionmentioning
confidence: 99%
“…Hypertrophic cardiomyopathy (HCM) is a relatively common, heritable cardiomyopathy with a prevalence of 1:200-1:500 [1]. HCM has a complex phenotypic and genetic expression and is characterized by left ventricular (LV) hypertrophy in the absence of loading conditions [1,2]. Myocardial fibrosis in HCM results in arrhythmias and even sudden cardiac death [3], and HCM consists of interstitial and replacement subtypes [4,5].…”
Section: Introductionmentioning
confidence: 99%